FDA Inspection 980903 — Teva Parenteral Medicines, Inc.

Teva Parenteral Medicines, Inc. — FEI 2027158

The FDA completed an inspection of Teva Parenteral Medicines, Inc. on July 29, 2016 in Irvine, CA. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
July 29, 2016
Fiscal Year
2016
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Irvine, CA (United States)